Advanced Glycation End Products Inhibit Glucose-Stimulated Insulin Secretion through Nitric Oxide-Dependent Inhibition of Cytochrome c Oxidase and Adenosine Triphosphate Synthesis
Open Access
- 26 February 2009
- journal article
- other
- Published by The Endocrine Society in Endocrinology
- Vol. 150 (6), 2569-2576
- https://doi.org/10.1210/en.2008-1342
Abstract
Advanced glycation end products (AGEs) are implicated in diabetic complications. However, their role in β-cell dysfunction is less clear. In this study we examined the effects of AGEs on islet function in mice and in isolated islets. AGE-BSA or BSA was administered ip to normal mice twice a day for 2 wk. We showed that AGE-BSA-treated mice exhibited significantly higher glucose levels and lower insulin levels in response to glucose challenge than did BSA-treated mice, although there were no significant differences in insulin sensitivity and islet morphology between two groups. Glucose-stimulated insulin secretion by islets of the AGE-BSA-treated mice or AGE-BSA-treated normal islets was significantly lower than that by islets isolated from the BSA-treated mice or BSA-treated normal islets. Furthermore, AGE treatment of islet β-cells inhibited ATP production, and glimepiride, a sulfonylurea derivative, restored glucose-stimulated insulin secretion. Further investigation indicated that AGEs inhibited cytochrome c oxidase activity by inducing the expression of inducible nitric oxide synthase (iNOS). Blocking the formation of nitric oxide with an iNOS selective inhibitor aminoguanidine reversed the inhibitory effects of AGEs on ATP production and insulin secretion. We conclude that AGEs inhibit cytochrome c oxidase and ATP production, leading to the impairment of glucose-stimulated insulin secretion through iNOS-dependent nitric oxide production.Keywords
This publication has 54 references indexed in Scilit:
- Calcium-independent Phospholipase A2 Localizes in and Protects Mitochondria during Apoptotic Induction by StaurosporineOnline Journal of Public Health Informatics, 2006
- Insulin resistance and pancreatic cell failureJCI Insight, 2006
- Islet cell failure in type 2 diabetesJCI Insight, 2006
- Diabetes and Advanced Glycoxidation End ProductsDiabetes Care, 2006
- Prevention of diabetic nephropathy in mice by a diet low in glycoxidation productsDiabetes/Metabolism Research and Reviews, 2002
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- Effect of Advanced Glycosylation End Products on the Induction of Nitric Oxide Synthase in Murine MacrophagesBiochemical and Biophysical Research Communications, 1996
- Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidaseFEBS Letters, 1994
- Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxideFEBS Letters, 1994
- Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function.JCI Insight, 1992